Medication Safety & High-Alert Drugs Nursing Guide 2026: ISMP List, Rights of Medication Administration

⚕️ Medical Disclaimer: This content is for educational purposes only and is intended for licensed healthcare professionals. It does not constitute medical advice and should not replace clinical judgment, facility protocols, or physician orders. Always verify medications, doses, and procedures with your institution's guidelines.

ISMP high-alert medications, 10 rights of administration, look-alike/sound-alike drug pairs, insulin safety, anticoagulant safety, medication error reporting, and TJC National Patient Safety Goals relevant to medications.

1. The 10 Rights of Medication Administration

Right Patient — 2 patient identifiers before every medication (name + DOB or MRN; NOT room number)
Right Drug — verify against MAR; read label 3 times (when taking from storage, when preparing, when administering)
Right Dose — calculate independently; use weight-based dosing when applicable; independent double-check for high-alert meds
Right Route — oral vs IV vs subQ vs IM vs topical; never assume route
Right Time — administer within 30 min of scheduled time (1 hr for non-time-critical); note onset/peak for monitoring
Right Documentation — document immediately after giving (never before); sign out controlled substances immediately
Right Reason — understand WHY the medication is prescribed; question orders that don't match diagnosis
Right Response — assess and document therapeutic effect; monitor for adverse effects
Right to Refuse — patient has the right to refuse; document refusal and notify provider
Right Education — patient understands what medication is for, how to take it, side effects to report

2. ISMP High-Alert Medications

High-alert medications are drugs that bear heightened risk of causing significant harm when used in error. They require independent double-checks, special labeling, and additional safeguards.

High-Alert Drug Categories (ISMP)

3. Look-Alike / Sound-Alike (LASA) Drug Pairs

Category	Examples	Key Safety Concern
Anticoagulants	Heparin IV, warfarin, LMWH (enoxaparin), DOACs (rivaroxaban, apixaban, dabigatran)	Bleeding; heparin 10 units/mL vs 1000 units/mL vs 25,000 units/bag confusion; independent double-check mandatory for IV heparin drip changes
Insulin	All insulins — regular, NPH, glargine (Lantus), lispro (Humalog), aspart (NovoLog), detemir	"U" for units abbreviation (can be misread as "0" → 10× overdose); always write "units"; U-500 insulin is 5× concentration; independent double-check
Opioids	IV morphine, hydromorphone (Dilaudid), fentanyl, oxycodone, methadone	Respiratory depression; hydromorphone 1 mg ≠ morphine 1 mg (hydromorphone ~5–7× more potent); PCA safety checks
Concentrated Electrolytes	Potassium chloride (KCl) >1 mEq/mL concentrate, hypertonic saline (3%, 23.4%), magnesium sulfate concentrate	KCl concentrate given IV push = cardiac arrest; NEVER store concentrated KCl on floors; must be diluted; 3% saline only in ICU with central line
Chemotherapy agents	Methotrexate, vincristine, cyclophosphamide, 5-fluorouracil	Vincristine: NEVER give intrathecally (fatal); must be labeled "For IV use only — Fatal if given intrathecally"; chemotherapy double-check required
Neuromuscular blocking agents	Succinylcholine, rocuronium, vecuronium, cisatracurium	Patient becomes apneic and fully paralyzed but may be fully awake and aware — MUST have sedation/analgesia; require ventilator; store separately from look-alikes
Hypertonic glucose	Dextrose 50% (D50W), dextrose 70%	Concentrated dextrose can cause vein damage; D50W for hypoglycemia; large-bore or central line preferred
Thrombolytics	Alteplase (tPA), tenecteplase, reteplase	Major bleeding risk; no IM injections; minimal lab draws; blood pressure management; abort protocol if ICH suspected

ISMP LASA Drugs — High-Priority Pairs to Know:

Drug 1	Drug 2	Risk
Morphine	Hydromorphone (Dilaudid)	Hydromorphone ~5-7× more potent; overdose deaths from mix-up
Heparin	Hespan (hetastarch)	Name similarity; heparin is anticoagulant
Insulin glargine (Lantus)	Insulin lispro (Humalog)	Both clear; glargine lasts 24h; lispro = rapid-acting
NovoLIN (human insulin)	NovoLOG (aspart)	Packaging similarity; different onset/duration
Metformin	Metronidazole	Name; completely different drugs
Hydroxyzine	Hydralazine	Name; hydroxyzine = antihistamine/anxiolytic; hydralazine = antihypertensive
Clonidine	Klonopin (clonazepam)	Sound-alike; clonidine = antihypertensive; clonazepam = benzo
Dopamine	Dobutamine	Both vasoactive; different receptor profiles; dopamine has renal dose effect; dobutamine increases contractility
Epinephrine	Ephedrine	Dose and potency vastly different
Vincristine	Vinblastine	Both vinca alkaloids; different dosing and toxicity profiles

4. Insulin Safety — Critical Points

Never abbreviate "units" as "U" — can be misread as "0" causing tenfold overdose. Always write out "units."
U-500 insulin is 5× the concentration of U-100 — only use U-500 syringes; never draw in U-100 syringe
Independent double-check required for all insulin drips and any high-dose insulin
Insulin drip protocol: check blood glucose q1h; if <70 stop drip and treat hypoglycemia per protocol
When transitioning from IV to subQ insulin: overlap subQ injection with IV drip by 1–2 hours before stopping drip
NPH is the ONLY insulin that is cloudy — all others should be clear; roll NPH (do NOT shake)
Lantus (glargine) and Levemir (detemir) are long-acting — should NEVER be mixed with other insulins
Rapid-acting insulins (lispro, aspart, glulisine): give with or just before meals; if patient not eating, hold

5. Anticoagulant Safety

6. Medication Error Reporting

Drug	Monitor	Reversal Agent	Key Safety Note
UFH (Unfractionated Heparin)	aPTT (therapeutic 60–100 sec for most indications)	Protamine sulfate 1 mg per 100 units UFH given in past 2–4 hr; max 50 mg	HIT: drop in platelets >50% on days 5–14 → STOP heparin (including heparin flushes); switch to argatroban or bivalirudin; NO warfarin until platelets recover; NO platelet transfusion
LMWH (Enoxaparin/Lovenox)	Anti-Xa level (not aPTT)	Protamine (partial ~60% reversal)	Renal dosing required; do NOT use in GFR <30 for treatment doses; rotate injection sites (abdomen preferred); leave air bubble in syringe when giving subQ
Warfarin	INR (therapeutic 2–3; mechanical valve 2.5–3.5)	Vitamin K (slow — hours to days); Kcentra (4-factor PCC) for urgent; FFP for emergent	Multiple drug and food interactions; monitor for signs of bleeding; consistent vitamin K intake (not avoid, but consistent); hold for invasive procedures (INR must be <1.5)
Dabigatran (Pradaxa)	No routine lab monitoring	Idarucizumab (Praxbind) — specific reversal agent	Renal excretion — avoid if GFR <30; take with food; store in original container (moisture-sensitive)
Rivaroxaban/Apixaban (Xarelto/Eliquis)	No routine monitoring	Andexanet alfa (Andexxa) for Xa inhibitors	Andexanet is expensive and limited; activated charcoal if recent ingestion; dialysis does NOT remove (high protein binding)

Types of medication errors:

Prescribing error: wrong drug, dose, route, frequency ordered
Dispensing error: pharmacy dispenses wrong drug or dose
Administration error: nurse gives wrong drug, dose, route, patient, or time
Monitoring error: failure to monitor for expected effects or toxicity

When an error occurs:

Assess patient safety FIRST — treat any adverse effects immediately
Notify the provider immediately
Document objectively in the medical record (what was given, when, patient response)
Complete an incident report (variance report) — this is NOT punitive; it's for system improvement
Do NOT document the incident report in the patient's chart
Pharmacy notification for any medication-related near-miss or error

NCLEX High-Yield: Medication Safety

Two patient identifiers before every medication — never use room number
High-alert meds require independent double-check: insulin drips, IV heparin, chemotherapy, concentrated electrolytes
KCl concentrate: NEVER give IV push — cardiac arrest. Must be diluted.
NMBA (neuromuscular blockers): patient may be AWAKE — always ensure sedation/analgesia is running
Vincristine: NEVER intrathecal — fatal
"U" for units: NEVER acceptable abbreviation — write "units"
HIT: platelets drop >50% on days 5–14 with heparin → STOP all heparin products
Hydromorphone (Dilaudid) is ~5–7× more potent than morphine — common cause of opioid overdose errors
Incident report: complete it; do NOT document it in the patient's medical chart
Insulin NPH: only cloudy insulin; roll, do not shake; can mix with regular insulin
Antidote: dabigatran = idarucizumab; rivaroxaban/apixaban = andexanet alfa; warfarin = Kcentra (urgent) or vitamin K; heparin = protamine sulfate

Get the ICU Notebook

Free investing strategies built for nurses. One email per week, no fluff.

Yes, send it free

No spam. Unsubscribe any time.

Medication Safety & High-Alert Drugs Nursing Guide 2026